Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis (Q33777535)

29 July 2017

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis (English)

1 reference

29 July 2017

0 references

Nick C Fox

6

0 references

David J. Brooks

object named as

David J Brooks

3

0 references

Reisa Sperling

1

object named as

Reisa Sperling

1 reference

29 July 2017

9

Lawrence S Honig

1 reference

29 July 2017

5

Jerome Barakos

1 reference

29 July 2017

15

Enchi Liu

1 reference

29 July 2017

20

Michael Grundman

1 reference

29 July 2017

2

Stephen Salloway

1 reference

29 July 2017

Donatella Tampieri

4

1 reference

29 July 2017

Murray Raskind

7

1 reference

29 July 2017

Marwan Sabbagh

8

1 reference

29 July 2017

Anton P Porsteinsson

10

1 reference

29 July 2017

Ivan Lieberburg

11

1 reference

29 July 2017

H Michael Arrighi

12

1 reference

29 July 2017

Kristen A Morris

13

1 reference

29 July 2017

Yuan Lu

14

1 reference

29 July 2017

Keith M Gregg

16

1 reference

29 July 2017

H Robert Brashear

17

1 reference

29 July 2017

Gene G Kinney

18

1 reference

29 July 2017

Ronald Black

19

1 reference

29 July 2017

3 February 2012

1 reference

29 July 2017

1 reference

29 July 2017

11

1 reference

29 July 2017

3

1 reference

29 July 2017

241-249

1 reference

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

A single ascending dose study of bapineuzumab in patients with Alzheimer disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Amyloid load in nondemented brains correlates with APOE e4.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Immunotherapy reduces vascular amyloid-beta in PDAPP mice.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Course of cerebral amyloid angiopathy-related inflammation.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Reversible leukoencephalopathy associated with cerebral amyloid angiopathy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Clinical manifestations of cerebral amyloid angiopathy-related inflammation

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

A new rating scale for age-related white matter changes applicable to MRI and CT.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4063417

Pathologic correlates of incidental MRI white matter signal hyperintensities

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22305802

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22305802

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22305802

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/S1474-4422(12)70015-7

1 reference

29 July 2017

1 reference

29 July 2017

1 reference